• Product NameGlycopyrrolate
  • CasNo. 596-51-0
  • MFC19H28BrNO3
  • MW398.34
  • Purity
  • AppearanceWhite crystalline powder
  • Packing
  • Contact usInquiry

Product Details

CasNo: 596-51-0

MF: C19H28BrNO3

Appearance: White crystalline powder

Buy Reliable Quality Glycopyrrolate,Export 596-51-0 Cheap Price

  • Molecular Formula:C19H28BrNO3
  • Molecular Weight:398.34
  • Appearance/Colour:White crystalline powder 
  • Melting Point:193 - 194.5oC 
  • Refractive Index:1.6200 (estimate) 
  • PSA:46.53000 
  • Density:1.3222 (rough estimate) 
  • LogP:-0.58090 

Glycopyrrolate(Cas 596-51-0) Usage

Description

Glycopyrrolate, also known as glycopyrronium, is an anticholinergic medication primarily utilized for its ability to inhibit the action of acetylcholine at muscarinic receptors in various organs and tissues throughout the body.

Chemical Properties

White Solid

Originator

Robinul,Robins,US,1961

Uses

Preoperative Medication: Glycopyrrolate is commonly administered before surgery to reduce salivary gland and respiratory secretions. By inhibiting these secretions, it helps maintain a clear airway during procedures.

Treatment of Stomach Ulcers: When used in combination with other medications, glycopyrrolate is indicated for the treatment of stomach ulcers in adults and children aged 12 and older. Stomach ulcers, also known as peptic ulcers, result from the erosion of the protective lining of the stomach due to excessive gastric acid production. Glycopyrrolate helps alleviate the symptoms associated with stomach ulcers.

Sialorrhea (Excessive Salivation): Glycopyrrolate is effective in managing sialorrhea, a condition characterized by excessive saliva production. It achieves this by inhibiting salivation, which can be beneficial in conditions where excessive drooling is a concern, such as in certain neurological disorders.

InChI:InChI=1/C20H30NO3.BrH/c1-21(2)13-12-18(15-21)24-19(22)14-20(23,17-10-6-7-11-17)16-8-4-3-5-9-16;/h3-5,8-9,17-18,23H,6-7,10-15H2,1-2H3;1H/q+1;/p-1

596-51-0 Relevant articles

Glycopyrrolate: pharmacokinetics and some pharmacodynamic findings

T. Ali-Melkkilä, T. Kaila, J. Kanto

Acta anaesthesiologica, Volume33, Issue6 August 1989 Pages 513-517

The correlation between the plasma concentration of glycopyrrolate and the drug effects appears to be variable. Because of its sensitivity, the RRA method proved to be quite useful in evaluating the kinetics of glycopyrrolate and its relationship to various clinical effects.

Glycopyrronium bromide intermediate as well as preparation method and application thereof

-

Paragraph 0078-0100, (2022/01/10)

The invention provides a glycopyrronium ...

596-51-0 Upstream products

  • 74-83-9
    74-83-9

    methyl bromide

  • 13118-11-1
    13118-11-1

    3-(2-cyclopentyl-2-hydroxy-2-phenylacetyloxy)-1-methylpyrrolidine

  • 13220-33-2
    13220-33-2

    1-methyl-3-pyrrolidinol

  • 427-49-6
    427-49-6

    2-cyclopentyl-2-hydroxy-2-phenylacetic acid

596-51-0 Downstream products

  • 873295-32-0
    873295-32-0

    3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium iodide

  • 873295-31-9
    873295-31-9

    [(cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium chloride

  • 873295-31-9
    873295-31-9

    [(cyclopentyl-hydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium chloride

  • 873295-45-5
    873295-45-5

    3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium benzoate

Relevant Products